Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers
NCT05314933
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Nasopharyngitis
Interventions
DRUG:
2-Deoxyglucose
OTHER:
Placebo
Sponsor
G.ST Antivirals GmbH